Torrent Pharmaceuticals Limited

Torrent Pharmaceuticals Torrent Research Center

Navin Vaya

Sunil Sadanand Nadkarni

Rajesh Singh Karan

Vinod Kumar Gupta

A novel modified release dosage form comprising of a high solubility active ingredient, which utilizes dual retard technique to effectively reduce the quantity of release controlling agents. Present invention can optionally comprise additionally another active ingredient as an immediate release form or modified release form. Present invention also relates to a process for preparing the said formulation.

Modified release composition for highly soluble drugs

A dosage form comprising of a high dose, high solubility active ingredient as modified release and a low dose active ingredient as immediate release where the weight ratio of immediate release active ingredient and modified release active ingredient is from 1:10 to 1:15000 and the weight of modified release active ingredient per unit is from 500 mg to 1500 mg; a process for preparing the dosage form.

Dosage form for high dose-high solubility active ingredients that provides for immediate release and modified release of the active ingredients

A novel modified release dosage form comprising of a high solubility active ingredient, which utilizes dual retard technique to effectively reduce the quantity of release controlling agents; a process for preparing the dosage form.

Modified release composition of highly soluble drugs

Dosage form

Rapidly disintegrating multiparticulate controlled release formulations of lamotrigine having an improved pharmacokinetic profile and improved patient compliance, and process of preparing the formulations. It provides better control of blood plasma levels than conventional tablet formulations that is administered once or more times a day.

Growing community of inventors

Gujarat, India

Navin Vaya